Investigation of Arm Swings Characteristics in Patient With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

Kronik Obstrüktif Akciğer Hastalığında Yürüyüş Sırasında Yürüyüşün Zaman Mesafe Karakteristikleri ve Kol Salınımlarının İncelenmesi

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05746702
• Other study ID #: GO 22/903
• Status: Recruiting
• Start date: March 1, 2023
• Est. completion date: October 19, 2024

Study information

• Verified date: July 2023
• Source: Hacettepe University
• Contact: Aynur Demirel, PhD
• Phone: +90 3123051576
• Email: aynur.demirel[@]hacettepe.edu.tr
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The former aim of this study is to determine whether the arm swings change in patients with Chronic Obstructive Pulmonary Disease (COPD) according to healthy subjects. The latter purposes to investigate the correlation between balance parameters and arm swing, how to change arm swing according to severity of the disease, and to determine the relationship between balance and the severity of disease, the relationship of posture both arm swing and severity of disease in patients with COPD. In accordance with this purposes, 20 patients with COPD who have Global Initiative for Chronic Obstruction Lung Disease (GOLD) stage 1-2-3 and 20 healthy controls will be included between the ages of 40 and 65, respectively. Tests and questionnaires will be used in order to determine the severity of COPD and to evaluate posture. Berg Balance Scale, Time Up and Go Test, 6 Minute Pegboard and Ring Test, 6 Minute Walk Test and gait analysis will be performed. It is expected that by determining the parameters that can be affected by severity of COPD. It is estimate to have information about severity of the disease by means of observational analysis. It will guide professional working in the field.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: October 19, 2024
• Est. primary completion date: June 19, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 65 Years

Eligibility

Inclusion Criteria:

• Who has been clinically stable for the last 4 weeks,

• who will be able to walk independently for 6 minutes,

• According to the Classification of Airflow Limitation in COPD (GOLD) system, the Stage is 1-2-3,

• who declares that he has not taken part in any other research

Exclusion Criteria:

• walking assistive devices,

• receiving chronic oxygen therapy,

• with central and peripheral vestibular disease,

• with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance,

• with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery,

• who has communication problems,

• with mental and cognitive problems

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Dyspnea
• Gait Disorders, Neurologic
• Gait, Unsteady
• Lung Diseases
• Lung Diseases, Obstructive
• Postural; Defect
• Pulmonary Disease, Chronic Obstructive

Locations

Country	Name	City	State
Turkey	Aynur Demirel	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Arm Swings Characteristics	Change of the arm swings during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.	1 day
Secondary	Spatiotemporal Characteristic	Change of the spatiotemporal characteristic during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.	1 day
Secondary	Upper Extremity Functional Capacity	Upper extremity functional capacity by 6 minute pegboard and ring test in patient with Chronic Obstructive Pulmonary Disease	1 day
Secondary	Balance	Balance by Berg Balance Scale and Time Up Go Test in patient with Chronic Obstructive Pulmonary Disease	1 day
Secondary	Severity of Disease	severity of disease by GOLD ( Global Initiative for Chronic Obstructive Pulmonary Disease) , CAT ( Chronic Respiratory Questionnaire), Pulmonary Function Test in patient with Chronic Obstructive Pulmonary Disease	1 day
Secondary	Posture	posture by Corbin Posture Analyses Form in patient with Chronic Obstructive Pulmonary Disease	1 day
Secondary	Functional Exercise Capacity	Functional exercise capacity by six minute gait test in patients with Chronic Obstructive Pulmonary Disease.	1 day